Could a simple shot replace IV drips for tough bone infections?
NCT ID NCT01815541
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tested whether giving the antibiotic teicoplanin as a shot under the skin is safe and well-tolerated in adults with bone and joint infections. Thirty patients who were already stable on IV teicoplanin received the subcutaneous version. The main goal was to check for injection-site reactions, not to measure how well the drug fought the infection.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- teicoplanin
- What this could lead to
- If successful, this could offer a more convenient way to give teicoplanin for bone infections, potentially reducing hospital stays.
- What could go wrong
- This is a small, early-phase study focused only on safety and local tolerance, not on whether the drug works. Results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOARTICULAR INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Amiens
Amiens, Picardie, 80054, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.